The medical gas and equipment market in China has evolved rapidly alongside the country’s expanding healthcare infrastructure and industrial modernization. Hospitals such as Peking Union Medical College Hospital in Beijing and Zhongshan Hospital in Shanghai have upgraded from traditional gas cylinders to centralized distribution networks that supply oxygen, nitrogen, medical air, nitrous oxide, and carbon dioxide through advanced pipeline systems. These infrastructures are essential in intensive care units, surgical theaters, and diagnostic laboratories across China’s urban hospitals. The National Health Commission has emphasized strict compliance with GB standards for medical gas production, purity, and safety in alignment with ISO and WHO protocols. The growing prevalence of chronic respiratory diseases, estimated to affect over 100 million Chinese citizens according to the China Pulmonary Health Study, has led to a sharp rise in oxygen therapy requirements, particularly in regions with high pollution levels such as Hebei and Sichuan. On-site oxygen generation using Pressure Swing Adsorption systems is increasingly common in both public and private hospitals, reducing dependence on bulk oxygen deliveries while improving supply continuity.

Smart monitoring technologies are being integrated into hospital building management systems, enabling real-time supervision of gas pressure, purity, and leakage. Cryogenic storage systems and manifold banks have been installed in large facilities like Ruijin Hospital to manage fluctuating ICU demands. The aging population has also accelerated adoption of portable oxygen concentrators in home healthcare, especially in provinces like Guangdong and Jiangsu. Environmental sustainability has become a key focus area, with state-owned producers implementing energy-efficient air separation units and cylinder recycling initiatives to cut industrial emissions. Engineering service providers are now responsible for routine system inspections and maintenance under guidelines from the Chinese Pharmacopoeia. According to the research report, "China Medical Gas and Equipment Market Research Report, 2030," published by Actual Market Research, the China Medical Gas and Equipment market is anticipated to grow at more than 8.00% CAGR from 2025 to 2030. Key domestic producers such as Hangzhou Hangyang, Beijing Praxair, and Yingde Gases dominate large-scale supply networks, while international companies including Linde and Air Liquide China have expanded partnerships to strengthen distribution and hospital infrastructure. The lessons from COVID-19 significantly accelerated modernization, leading to the installation of on-site oxygen plants at hospitals like Huoshenshan in Wuhan and West China Hospital in Chengdu.

The Chinese government has since mandated that all Tier 3 hospitals maintain emergency oxygen capacity and digital monitoring systems. AI-driven automation and IoT-based gas management solutions are being implemented in newer facilities such as Shenzhen People’s Hospital, where control units track gas flow and detect faults instantly. Startups like Inmatec China and Foshan Yongheng have introduced compact PSA generators for rural hospitals and mobile clinics to support healthcare access in western provinces such as Gansu and Xinjiang. Public-private collaborations under the Healthy China 2030 policy have increased funding for ICU modernization, biomedical gas research, and local production of medical-grade equipment. The logistics network supporting gas supply has been enhanced through cryogenic tankers, automated refilling stations, and cold chain storage hubs in major industrial regions. Home oxygen therapy adoption is growing due to the increasing elderly population, with companies such as Mindray and Yuyue Medical producing affordable concentrators and remote monitoring devices.

Universities and research institutions including Tsinghua University and Shanghai Jiao Tong University are conducting studies on gas-based sterilization, anesthesia optimization, and cryogenic preservation in biotechnology. The State Administration for Market Regulation continues to enforce strict certification protocols to ensure safety in gas production, storage, and delivery. In China the market for medical gases and equipment is characterised by two intimately connected segments the supply of medical-grade gases and the infrastructure and devices that deliver those gases safely to end-users. On the gases side Chinese companies produce and distribute gases such as oxygen, nitrous oxide, nitrogen, carbon dioxide and medical air to hospitals in major metropolitan areas like Beijing, Shanghai and Guangzhou as well as to remote regions in provinces such as Heilongjiang and Yunnan. On the equipment side Chinese manufacturers and domestic suppliers provide equipment that includes on-site oxygen generator systems, cylinder filling stations, manifold banks, medical-gas pipeline installations, bed-head terminal units, flowmeters, vacuum stations and alarm systems, with firms active in provinces such as Jiangsu and Hunan. The regulatory environment in China mandates that medical gases meet purity and safety specifications while delivery equipment installed in hospitals and clinics must comply with applicable standards for patient safety and biomedical engineering.

In hospitals in Shanghai and Beijing pipeline networks and bulk liquid tanks feed intensive-care units and operating theatres whereas home-care and smaller community hospitals often utilise cylinder banks and portable concentrators. Equipment innovations have also emerged with pressure-swing adsorption (PSA) oxygen generator systems located on hospital grounds to reduce dependence on external cylinder logistics. Equipment manufacturers based in Zhejiang provide modular pipeline systems and mobile manifold units to serve satellite clinics and rural health stations. In China the applications for medical gases and associated equipment span therapeutic care, diagnostics, pharmaceutical manufacturing and miscellaneous other uses across a broad healthcare ecosystem. Therapeutically in urban hospitals such as those in Shenzhen and Chengdu patients suffering from respiratory conditions receive oxygen therapy supported by central gas supply systems, concentrators, and ventilation equipment while rural clinics in provinces such as Gansu rely on mobile cylinder systems and compact delivery hardware. In diagnostic applications hospitals in cities like Wuhan and Xi’an utilise carbon dioxide for laparoscopic insufflation during minimally invasive surgeries and helium or nitrogen gases within MRI and CT systems for cooling or calibration, and laboratory facilities in teaching hospitals deploy mixtures of gases for analytical equipment calibration.

The pharmaceutical industry in China, with major production hubs in Zhejiang and Guangdong provinces, uses high-purity nitrogen and oxygen in sterile manufacturing, cryopreservation of cells and analytic labs, with dedicated supply lines and delivery equipment designed for GMP-compliant operations. Other applications include nitrous oxide used in dental clinics and outpatient surgical centres in municipal areas such as Hangzhou, gas-driven pneumatic tools in biomanufacturing plants in Suzhou and portable oxygen units for emergency response in remote mountainous regions of Qinghai. The regulatory framework of the Chinese Ministry of Health and corresponding provincial authorities enforces gas quality standards and equipment maintenance protocols across all of these application zones thereby enabling the integrated use of gaseous-media and delivery systems in China’s healthcare and life-science sectors.In China the end-users of medical gases and equipment encompass hospitals, home-health-care services, ambulatory surgical centres, pharmaceutical and biotechnology firms and academic and research institutions, each with their own infrastructure needs and delivery requirements. Hospitals in major cities like Beijing and Shanghai operate large-scale central gas plants and pipeline systems that feed intensive-care units, operating theatres and large bed-head installations. Home-health-care services provide portable oxygen concentrators and cylinder systems to patients in urban apartments and in rural regions such as Inner Mongolia and Yunnan under regional health-care programmes. Ambulatory surgical centres in cities like Guangzhou and Chongqing deploy compact gas delivery equipment and manifold systems to support day-surgery and outpatient procedures outside traditional inpatient hospital frameworks.

Pharmaceutical and biotechnology companies in industrial parks around Shenzhen and Suzhou install ultra-high-purity gas systems and precision delivery equipment for research, development and manufacturing operations under stringent regulatory oversight. Academic and research institutions, including universities in Nanjing and Wuhan, maintain specialized pipeline installations, controlled gas-storage facilities and delivery systems to support biomedical research and teaching hospitals. Considered in this report• Historic Year: 2019• Base year: 2024• Estimated year: 2025• Forecast year: 2030Aspects covered in this report• Medical Gas and Equipment Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Type• Medical Gases• Medical Gas EquipmentBy Application• Therapeutic• Diagnostic• Pharmaceutical Industry• OthersBy End-User • Hospitals• Home Healthcare• Ambulatory Surgical Centers• Pharmaceutical & Biotechnology Companies• Academic & Research Institutions.